Fintech

Novo Nordisk Wins FDA Nod For First-Ever Weekly Basal Insulin

Benzinga·March 27, 2026 at 12:04 PM

FDA approves Novo Nordisk once-weekly insulin Awiqli for Type 2 diabetes, offering an alternative to daily injections.

Original Source

Related in Fintech

Novo Nordisk Wins FDA Nod For First-Ever Weekly Basal Insulin​